ProKidney to Participate in Two Upcoming Conferences: Guggenheim Healthcare Innovation Conference and the Jefferies Global Healthcare Conference

Rhea-AI Summary

ProKidney (Nasdaq: PROK) said senior management will participate in two healthcare conferences in November 2025: a fireside chat at the Guggenheim Healthcare Innovation Conference in Boston on Wednesday, November 12, 2025 at 10:00 AM ET, and one‑on‑one meetings at the Jefferies Global Healthcare Conference in London on November 17–20, 2025.

The Guggenheim fireside chat will be webcast live and the replay will be available in the Events section of ProKidney’s Investor Relations website at www.prokidney.com. Investors seeking one‑on‑one meetings at Jefferies should contact their banking representatives.

WINSTON-SALEM, N.C., Oct. 29, 2025 (GLOBE NEWSWIRE) -- ProKidney Corp. (Nasdaq: PROK) (“ProKidney” or the “Company"), a leading late clinical-stage cellular therapeutics company focused on chronic kidney disease (CKD), today announced that senior members of the management team will be participating in the following two upcoming healthcare conferences in November:

Guggenheim Healthcare Innovation Conference (Boston)
Date: Wednesday, November 12, 2025
Time: 10:00am ET
Format: Fireside Chat
Webcast: Link

Jefferies Global Healthcare Conference (London)
Dates: November 17-20, 2025
Format: 1x1 Meetings

The live webcast of the fireside chat will be accessible through the “Events” section of the Investor Relations tab within ProKidney’s website at www.prokidney.com. Investors interested in one-on-one meetings should contact their banking representatives.

About ProKidney Corp.
ProKidney, a pioneer in the treatment of CKD through innovations in cellular therapy, was founded in 2015 after a decade of research. ProKidney’s lead product candidate, rilparencel (also known as REACT^®), is a first-in-class, patented, proprietary autologous cellular therapy with regenerative medicine advanced therapy designation that is being evaluated in the ongoing Phase 3 REGEN-006 (PROACT 1) study for its potential to preserve kidney function in patients with advanced CKD and type 2 diabetes. For more information, please visit www.prokidney.com.

ProKidney Contact
Ethan Holdaway
Ethan.Holdaway@prokidney.com

Media Contact
Audra Friis 
audrafriis@sambrown.com

Investor Relations Contact
Daniel Ferry
Daniel@lifesciadvisors.com

FAQ

When will ProKidney (PROK) present at the Guggenheim Healthcare Innovation Conference?

ProKidney will present a fireside chat on Wednesday, November 12, 2025 at 10:00 AM ET.

How can I watch ProKidney's (PROK) Guggenheim fireside chat webcast?

The live webcast will be available via the Events section of ProKidney’s Investor Relations website at www.prokidney.com.

On what dates will ProKidney (PROK) attend the Jefferies Global Healthcare Conference in London?

ProKidney management will participate in one‑on‑one meetings at the Jefferies conference from November 17–20, 2025.

How can investors request one‑on‑one meetings with ProKidney (PROK) at Jefferies?

Investors should contact their banking representatives to request one‑on‑one meetings.

Will the Guggenheim webcast of ProKidney (PROK) be archived for later viewing?

Yes, the webcast replay will be accessible in the Events section of ProKidney’s Investor Relations website.

What topics will ProKidney (PROK) management likely cover at the November 2025 conferences?

Management is expected to discuss corporate updates and clinical-stage progress in chronic kidney disease; conference formats include a fireside chat and 1x1 meetings.